Jiney Jose is a medicinal chemist specialising in the development of small molecule therapeutics for cancer treatment. His primary research focuses on designing and advancing tumour targeted theranostic agents with brain‑penetrant properties for the treatment of paediatric and adult brain cancers. His broader research interests include cancer immunotherapy, short acting anaesthetics, and near infrared organic fluorophores. He co‑supervises Honours, Master’s, and PhD students across multiple research projects and contributes actively to postgraduate teaching. He also serves as a reviewer for several scientific funding bodies and journals. Over the years, he has established strong national and international collaborations to accelerate drug development for cancer therapy. Jiney is a co‑founding scientist of Kea Therapeutics, a biotechnology company focused on the preclinical development of short‑acting anaesthetics. His research has been supported by major funding bodies, including the Wellcome Trust (UK), the Health Research Council of New Zealand, Royal Society Te Apārangi, Cancer Research Trust New Zealand, Cure Kids, the Neurological Foundation of New Zealand, the Hugh Green Foundation, and the Auckland Cancer Society (Auckland/Northland).